Jardiance 10 mg (Tablet)
Unit Price: ৳ 69.00 (9 x 10: ৳ 6,210.00)
Strip Price: ৳ 690.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Boehringer ingelheim |
| Also available as |
Title
- Jardiance 10 mg Tablet
Categories
- Medicine
- Diabetes management
- Cardiovascular health
Description
- SGLT-2 inhibitor for type 2 diabetes mellitus
- Reduces risk of cardiovascular death
- Pharmacological action in kidney for glucose reabsorption
- Dosage of 10 mg once daily, may increase to 25 mg
- Interactions with diuretics, insulin, and urine glucose tests
- Contraindications for serious hypersensitivity reaction, severe renal impairment, end-stage renal disease, or dialysis
- Common adverse reactions include urinary tract and genital infections, dehydration, hypotension, weakness, dizziness, increased thirstiness
- Pregnancy and lactation warnings
- Renal function assessment and precautions
- Overdose effects and storage conditions
- Chemical structure with molecular formula
Dosage & Administration
- 10 mg once daily
- Morning intake
- With or without food
Pharmacological Action
- SGLT-2 inhibition
- Glucuretic effect
- Renal glucose excretion
- Weight loss
- Blood pressure reduction
Interaction
- Diuretics - increased urine volume
- Insulin or Insulin Secretagogues - risk of hypoglycemia
- Positive Urine Glucose Test - alternative monitoring methods recommended
- Interference with 1,5-anhydroglucitol (1,5-AG) Assay - unreliable measurements
Contraindications
- History of serious hypersensitivity reaction
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Use if potential benefit justifies potential risk to fetus
- Not recommended during breastfeeding
Precautions & Warnings
- Assessment of renal function prior to initiation
- Not initiated in patients with eGFR less than 45 ml/min/1.73 m^2
Overdose Effects
- Supportive measures
- Clinical monitoring
- Supportive treatment
- Hemodialysis not studied for removal
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Keep in cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children